131 related articles for article (PubMed ID: 31212287)
1. Impact of Body Mass Index and Pretreatment Hemoglobin Level on Prognosis Following Radical Cystectomy for Bladder Cancer in Males and Females.
Bi H; Huang Y; Wang G; Ma L; Lu M
Urol Int; 2020; 104(1-2):28-35. PubMed ID: 31212287
[TBL] [Abstract][Full Text] [Related]
2. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
[TBL] [Abstract][Full Text] [Related]
3. Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
Gierth M; Zeman F; Denzinger S; Vetterlein MW; Fisch M; Bastian PJ; Syring I; Ellinger J; Müller SC; Herrmann E; Gilfrich C; May M; Pycha A; Wagenlehner FM; Vallo S; Bartsch G; Haferkamp A; Grimm MO; Roigas J; Protzel C; Hakenberg OW; Fritsche HM; Burger M; Aziz A; Mayr R
Urol Int; 2018; 101(1):16-24. PubMed ID: 29719296
[TBL] [Abstract][Full Text] [Related]
4. Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.
Grimm T; Buchner A; Schneevoigt B; Kretschmer A; Apfelbeck M; Grabbert M; Jokisch JF; Stief CG; Karl A
World J Urol; 2016 May; 34(5):703-8. PubMed ID: 26376992
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index on radical cystectomy.
Lee CT; Dunn RL; Chen BT; Joshi DP; Sheffield J; Montie JE
J Urol; 2004 Oct; 172(4 Pt 1):1281-5. PubMed ID: 15371824
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.
Schubert T; Todenhöfer T; Mischinger J; Schwentner C; Renninger M; Stenzl A; Gakis G
World J Urol; 2016 Jun; 34(6):829-34. PubMed ID: 26420594
[TBL] [Abstract][Full Text] [Related]
7. Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.
Murakami Y; Matsumoto K; Ikeda M; Utsunomiya T; Hirayama T; Koguchi D; Matsuda D; Okuno N; Taoka Y; Irie A; Iwamura M
Asia Pac J Clin Oncol; 2018 Aug; 14(4):310-317. PubMed ID: 29356359
[TBL] [Abstract][Full Text] [Related]
8. Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy.
Kwon T; Jeong IG; You D; Han KS; Hong S; Hong B; Hong JH; Ahn H; Kim CS
Int J Urol; 2014 Nov; 21(11):1106-12. PubMed ID: 25039565
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
10. Extreme body mass index is associated with poor survival outcomes after radical cystectomy: a retrospective cohort study in a Chinese population.
Huang X; Jin S; Liu S; Geng J
Transl Androl Urol; 2021 Oct; 10(10):3852-3861. PubMed ID: 34804827
[TBL] [Abstract][Full Text] [Related]
11. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
12. Impact of body mass index on clinical and cost outcomes after radical cystectomy.
Bagrodia A; Grover S; Srivastava A; Gupta A; Bolenz C; Sagalowsky AI; Lotan Y
BJU Int; 2009 Aug; 104(3):326-30. PubMed ID: 19220244
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.
Hofner T; Macher-Goeppinger S; Klein C; Schillert A; Eisen C; Wagner S; Rigo-Watermeier T; Baccelli I; Vogel V; Trumpp A; Sprick MR
Urol Oncol; 2014 Jul; 32(5):678-86. PubMed ID: 24631171
[TBL] [Abstract][Full Text] [Related]
14. An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
Ferro M; Vartolomei MD; Russo GI; Cantiello F; Farhan ARA; Terracciano D; Cimmino A; Di Stasi S; Musi G; Hurle R; Serretta V; Busetto GM; De Berardinis E; Cioffi A; Perdonà S; Borghesi M; Schiavina R; Cozzi G; Almeida GL; Bove P; Lima E; Grimaldi G; Matei DV; Crisan N; Muto M; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Shariat S; Mirone V; Lucarelli G
World J Urol; 2019 Mar; 37(3):507-514. PubMed ID: 29992381
[TBL] [Abstract][Full Text] [Related]
15. Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
Dabi Y; Rouscoff Y; Anract J; Delongchamps NB; Sibony M; Saighi D; Zerbib M; Peyraumore M; Xylinas E
World J Urol; 2017 Feb; 35(2):229-235. PubMed ID: 27272203
[TBL] [Abstract][Full Text] [Related]
16. Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
Ahmadi N; Clifford TG; Miranda G; Cai J; Aron M; Desai MM; Gill IS
BJU Int; 2017 Nov; 120(5):689-694. PubMed ID: 28544311
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
18. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
Mitra AP; Skinner EC; Schuckman AK; Quinn DI; Dorff TB; Daneshmand S
Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
[TBL] [Abstract][Full Text] [Related]
20. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
